The Global Renal Denervation Market Size accounted for USD 198.1 Million in 2021 and is projected to achieve a market size of USD 4,464.6 Million by 2030 rising at a CAGR of 41.5% from 2022 to 2030. Increasing incidences of hypertension, changing lifestyle, and long-term positive effect of renal denervation procedure are the key factors driving market. Increasing cases of therapy-resistant hypertension is among one of the prime growth-driving factors for the global renal denervation market. Hypertension is a long term medical condition and is among the most common diseases in the world also without any major symptoms.
Renal Denervation Market Report Statistics
The global renal denervation market in developed economies, such as Italy, the U.K., and France, is moderately mature as compared to other developing and under-developed economies attributable to the presence of major companies in these countries and high awareness and demand among the population for such products. Europe constituted the largest share due to the technological advancements and increase in number of drug-resistant hypertension cases in the regional market.
Global Renal Denervation Market Dynamics
Renal Denervation Market Report Coverage
|Market||Renal Denervation Market|
|Renal Denervation Market Size 2021||USD 198.1 Million|
|Renal Denervation Market Forecast 2030||USD 4,464.6 Million|
|Renal Denervation Market CAGR During 2022 - 2030||41.5%|
|Renal Denervation Market Analysis Period||2018 - 2030|
|Renal Denervation Market Base Year||2021|
|Renal Denervation Market Forecast Data||2022 - 2030|
|Segments Covered||By Product Type, By Technology, By Indication, By End-User, And By Geography
|Regional Scope||North America, Europe, Asia Pacific, Latin America, and Middle East & Africa|
|Key Companies Profiled||Medtronic PLC, Cardiosonic, Inc., Kona Medical, Inc., Abbott Laboratories, Ablative Solutions, Inc., Renal Dynamics, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corp., and Symple Surgical, Inc.|
||Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis|
Renal Denervation Market Growth Factors
Availability of improved and alternative technology, such as micro-infusion, for renal denervation systems and better healthcare infrastructures in emerging economies are also expected to enhance market growth. For instance, Mercator MedSystem’s micro-infusion based renal denervation system reduces the blood pressure in patients, by delivering to its agents at a specific site to denervate the renal artery.
Renal Denervation Market Insights
In 2013, according to the Centers for Disease Control and Prevention (CDC), over 3.6lakh people in the U.S. died because of high blood pressure. The occurrence of hypertension has augmented from 17,307 per 100,000 in 1990 to 20,525 per 100,000 in 2015. However, the renal denervation therapy has also shown a optimistic result in minimizing hypertension. Consequently, the advantages offered by such therapies, for instance reduced treatment time, higher safety, and permanent effects are boosting the market growth. Moreover, technological advancement in renal denervation devices is likely to drive the market.
Renal Denervation Market Segmentation
The global renal denervation market is segmented based on product type, technology, indication, end-user, and geography.
Renal Denervation Market By Product Type
Renal Denervation Market By Technology
Renal Denervation Market By Indication
Renal Denervation Market By End-User
Renal Denervation Market Regional Outlook
The Middle East & Africa
Renal Denervation Market Regional Analysis
In 2021, Europe led the renal denervation market in terms of regions and is anticipated to maintain the dominance even during the forecast period. North America renal denervation market is projected to follow Europe, in terms of revenue generation, during the forecast period due to the increasing number of filings for FDA approvals in the U.S. Rising occurrence of uncontrolled hypertension is also one of the key factors responsible for the North America renal denervation market growth. Asia-Pacific renal denervation market is anticipated to experience the fastest growth over the forecast period owing to rising cases of obesity, diabetes, and other lifestyle related diseases. Also, the presence of a large target population base in developing economies like China and Japan are the main drivers for the market growth in Asia-Pacific region.
Renal Denervation Market Players
The key players catering to the global renal denervation market are Medtronic PLC, Cardiosonic, Inc., Kona Medical, Inc., Abbott Laboratories, Ablative Solutions, Inc., Renal Dynamics, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corp., and Symple Surgical, Inc. The global players are continuously investing in R&D activities and innovating to have updated technology-based product portfolio to attract more and more business opportunity from the emerging nation such as that in Asia Pacific countries.
In April 2021, Medtronic collaborated with Surgical Theater, a developer of technology for patients based on fighter aircraft flight simulation. As a result of this collaboration, Medtronic will integrate the Surgical Theater's SyncAR Augmented Reality technology with StealthStation S8 Surgical Navigation System, allowing neurosurgeons to use real-time AR technology to improve visualisation during difficult cranial surgery.
The market size of renal denervation market in 2021 was accounted to be USD 198.1 Million.
The projected CAGR of renal denervation market during the analysis period of 2022 to 2030 is 41.5%.
The prominent players of the global renal denervation market include Medtronic PLC, Cardiosonic, Inc., Kona Medical, Inc., Abbott Laboratories, Ablative Solutions, Inc., Renal Dynamics, Mercator MedSystems, Inc., ReCor Medical, Inc., Boston Scientific Corp., and Symple Surgical, Inc.
Europe held the dominating renal denervation during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for renal denervation during the analysis period of 2022 to 2030.
Increasing prevalence of hypertension, long-lasting effect of procedure, and changing lifestyle of people drives the growth of global renal denervation market.
Based on product type, symplicity segment is expected to hold the maximum share renal denervation market.